Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. (Q54139769)

25 May 2018

title

Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. (English)

1 reference

25 May 2018

Mycobacterium avium avium

main subject

1 reference

E Jarboe

1

1 reference

25 May 2018

B L Stone

2

1 reference

25 May 2018

W J Burman

3

1 reference

25 May 2018

R J Wallace

4

1 reference

25 May 2018

B A Brown

5

1 reference

25 May 2018

R R Reves

6

1 reference

25 May 2018

M L Wilson

7

1 reference

25 May 2018

publication date

1 March 1998

1 reference

25 May 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

25 May 2018

volume

30

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

197-203

1 reference

25 May 2018

Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Mycobacterium avium strains resistant to clarithromycin and azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Antimycobacterial susceptibility testing: present practices and future trends

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

Effect of Temperature on the Rate of the Transparent to Opaque Colony Type Transition in Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2897%2900241-1

7 January 2021

10.1016/S0732-8893(97)00241-1

Identifiers

DOI

1 reference

25 May 2018

release_cll3i7ilczbpxckpyimm562sg4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cll3i7ilczbpxckpyimm562sg4

24 November 2022

mapped directly with Wikidata item

PubMed ID

9572027

1 reference

25 May 2018